AAV2.7m8 is a powerful viral vector for inner ear gene therapy

Area of Science:

• Otic biology
• Gene therapy vectors
• Molecular virology

Background:

• Hereditary hearing loss often involves mutations affecting cochlear hair cells.
• Conventional adeno-associated virus (AAV) vectors show variable efficiency in targeting inner ear cells.
• Outer hair cells (OHCs) and supporting cells are poorly infected by standard AAVs.

Purpose of the Study:

• To evaluate the infection patterns of synthetic AAV vectors in the mouse inner ear.
• To determine the efficiency of AAV2.7m8 and AAV8BP2 in targeting cochlear cells.
• To identify improved viral vectors for inner ear gene therapy.

Main Methods:

• Administration of two synthetic AAV vectors, AAV2.7m8 and AAV8BP2, into the mouse inner ear.
• Analysis of viral vector infection patterns in cochlear hair cells (inner hair cells [IHCs] and outer hair cells [OHCs]) and supporting cells.
• Microscopic examination of viral transduction in specific cochlear cell types.

Main Results:

• AAV2.7m8 demonstrated high infection efficiency in both inner hair cells (IHCs) and outer hair cells (OHCs).
• AAV2.7m8 also effectively infected inner pillar cells and inner phalangeal cells.
• AAV8BP2 showed different infection patterns, with AAV2.7m8 being superior for hair and supporting cell targeting.

Conclusions:

• AAV2.7m8 is a highly effective viral vector for targeting cochlear hair cells and supporting cells in the mouse inner ear.
• This synthetic AAV vector holds significant potential for advancing gene therapy strategies for hereditary hearing loss.
• AAV2.7m8 may broaden the scope of applications for inner ear gene therapy.